{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:38Z","timestamp":1792785098638,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Merrigan Fellowship"},{"name":"Stanford University Medical Scientist Training Program grant","award":["T32-GM007365"],"award-info":[{"award-number":["T32-GM007365"]}],"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Stanford Interdisciplinary Graduate Fellowship, Gold Family Graduate Fellow"},{"name":"National Institutes of Health grant","award":["R01 HL148184-01, R01 AI12492093, R01 DC019965"],"award-info":[{"award-number":["R01 HL148184-01, R01 AI12492093, R01 DC019965"]}]},{"name":"Cystic Fibrosis Foundation (CFF), the Cystic Fibrosis Research Institute (CFRI) and the Emerson Collective grant","id":[{"id":"https:\/\/ror.org\/037fnx337","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["HHSN272201700020I, Task Order 75N93021F00003 (A-57)"],"award-info":[{"award-number":["HHSN272201700020I, Task Order 75N93021F00003 (A-57)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"DOI":"10.1038\/s44298-026-00220-6","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:52:44Z","timestamp":1786344764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-step monolithic chromatography efficiently purifies diverse Pseudomonas aeruginosa phages with therapeutic-grade endotoxin reduction"],"prefix":"10.1038","volume":"4","author":[{"given":"Arne","family":"Echterhof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Dharmaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hajfathalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis G.","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Bollyky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"220_CR1","doi-asserted-by":"crossref","unstructured":"Chen, Q. et al. Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics. Pharmaceutics 14, 1425 (2022).","DOI":"10.3390\/pharmaceutics14071425"},{"key":"220_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.1934.72750490003007","volume":"103","author":"MD Eaton","year":"1934","unstructured":"Eaton, M. D. & Bayne Jones, S. Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. J. Am. Med. Assoc. 103, 1769\u20131776 (1934).","journal-title":"J. Am. Med. Assoc."},{"key":"220_CR3","first-page":"329","volume":"7","author":"F d\u2019Herelle","year":"1931","unstructured":"d\u2019Herelle, F. Bacteriophage as a treatment in acute medical and surgical infections. Bull. N. Y. Acad. Med. 7, 329\u2013348 (1931).","journal-title":"Bull. N. Y. Acad. Med."},{"key":"220_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","volume":"20","author":"DGJ Larsson","year":"2021","unstructured":"Larsson, D. G. J. & Flach, C. F. Antibiotic resistance in the environment. Nat. Rev. Microbiol. 20, 257\u2013269 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"220_CR5","unstructured":"World Health Organisation. Antibacterial Agents in Clinical and Preclinical Development: an overview and analysis. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (2022)."},{"key":"220_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00408-024-00700-7","volume":"202","author":"A Khosravi","year":"2024","unstructured":"Khosravi, A., Chen, Q., Echterhof, A., Koff, J. L. & Bollyky, P. L. Phage therapy for respiratory infections: opportunities and challenges. Lung 202, 223\u2013232 (2024).","journal-title":"Lung"},{"key":"220_CR7","doi-asserted-by":"crossref","unstructured":"Aslam, S. et al. Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States. Open Forum Infect. Dis. 7, ofaa389 (2020).","DOI":"10.1093\/ofid\/ofaa389"},{"key":"220_CR8","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"220_CR9","unstructured":"CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) ClinicalTrials.gov identifier: NCT04684641. https:\/\/clinicaltrials.gov\/study\/NCT04684641 (2023)."},{"key":"220_CR10","unstructured":"Nebulized bacteriophage therapy in cystic fibrosis patients with chronic pseudomonas aeruginosa pulmonary infection. ClinicalTrials.gov identifier: NCT05010577. https:\/\/clinicaltrials.gov\/study\/NCT05010577 (2023)."},{"key":"220_CR11","doi-asserted-by":"crossref","unstructured":"Villalpando-Aguilar, J. L., Matos-Pech, G., L\u00f3pez-Rosas, I., Castel\u00e1n-S\u00e1nchez, H. G. & Alatorre-Cobos, F. Phage therapy for crops: concepts, experimental and bioinformatics approaches to direct its application. Int. J. Mol. Sci. 24, 325 (2022).","DOI":"10.3390\/ijms24010325"},{"key":"220_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1021\/acssynbio.5b00296","volume":"5","author":"J Garamella","year":"2016","unstructured":"Garamella, J., Marshall, R., Rustad, M. & Noireaux, V. The all E. coli TX-TL toolbox 2.0: a platform for cell-free synthetic biology. ACS Synth. Biol. 5, 344\u2013355 (2016).","journal-title":"ACS Synth. Biol."},{"key":"220_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.chembiol.2022.06.003","volume":"29","author":"Q Emslander","year":"2022","unstructured":"Emslander, Q. et al. Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria. Cell Chem. Biol. 29, 1434\u20131445.e7 (2022).","journal-title":"Cell Chem. Biol."},{"key":"220_CR14","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1021\/acssynbio.2c00244","volume":"11","author":"SBW Liyanagedera","year":"2022","unstructured":"Liyanagedera, S. B. W. et al. SpyPhage: a cell-free TXTL platform for rapid engineering of targeted phage therapies. ACS Synth. Biol. 11, 3330\u20133342 (2022).","journal-title":"ACS Synth. Biol."},{"key":"220_CR15","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1021\/acssynbio.3c00239","volume":"12","author":"R Brooks","year":"2023","unstructured":"Brooks, R., Morici, L. & Sandoval, N. Cell free bacteriophage synthesis from engineered strains improves yield. ACS Synth. Biol. 12, 2418\u20132431 (2023).","journal-title":"ACS Synth. Biol."},{"key":"220_CR16","doi-asserted-by":"publisher","first-page":"e0150625","DOI":"10.1128\/aac.01506-25","volume":"70","author":"A Echterhof","year":"2026","unstructured":"Echterhof, A. Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model. Antimicrob. Agents Chemother. 70, e0150625 (2026).","journal-title":"Antimicrob. Agents Chemother."},{"key":"220_CR17","doi-asserted-by":"publisher","unstructured":"Lin, Y.-H. et al. Dosing and delivery of bacteriophage therapy in a murine wound infection model. Preprint at https:\/\/doi.org\/10.1101\/2024.05.07.593005 (2025).","DOI":"10.1101\/2024.05.07.593005"},{"key":"220_CR18","doi-asserted-by":"publisher","first-page":"1250339","DOI":"10.3389\/fcimb.2023.1250339","volume":"13","author":"N Pennetzdorfer","year":"2023","unstructured":"Pennetzdorfer, N. et al. Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection. Front. Cell. Infect. Microbiol. 13, 1250339 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"220_CR19","doi-asserted-by":"publisher","unstructured":"Dharmaraj, T. et al. Rapid assessment of changes in phage bioactivity using dynamic light scattering. PNAS Nexus 2, https:\/\/doi.org\/10.1101\/2023.07.02.547396 (2023).","DOI":"10.1101\/2023.07.02.547396"},{"key":"220_CR20","first-page":"1","volume":"15","author":"MK Kim","year":"2024","unstructured":"Kim, M. K. et al. A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections. Nat. Commun. 2024 15, 1\u201315 (2024).","journal-title":"Nat. Commun. 2024"},{"key":"220_CR21","doi-asserted-by":"crossref","unstructured":"Echterhof, A. et al. The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo. JCI Insight 9, e181309 (2024).","DOI":"10.1172\/jci.insight.181309"},{"key":"220_CR22","first-page":"31","volume":"10","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Pf bacteriophages hinder sputum antibiotic diffusion via electrostatic binding. Sci. Adv. 10, 31 (2024).","journal-title":"Sci. Adv."},{"key":"220_CR23","doi-asserted-by":"crossref","unstructured":"Burgener, E. B. et al. The lysogenic filamentous Pseudomonas bacteriophage phage Pf slows mucociliary transport. PNAS Nexus 3, pgae390 (2024).","DOI":"10.1093\/pnasnexus\/pgae390"},{"key":"220_CR24","doi-asserted-by":"crossref","unstructured":"Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363, eaat9691 (2019).","DOI":"10.1126\/science.aat9691"},{"key":"220_CR25","doi-asserted-by":"crossref","unstructured":"Chaiwut, R. & Kasinrerk, W. Very low concentration of lipopolysaccharide can induce the production of various cytokines and chemokines in human primary monocytes. BMC Res. Notes 15, 42 (2022).","DOI":"10.1186\/s13104-022-05941-4"},{"key":"220_CR26","doi-asserted-by":"publisher","first-page":"21584","DOI":"10.1074\/jbc.M114.583518","volume":"289","author":"MC Morris","year":"2014","unstructured":"Morris, M. C., Gilliam, E. A., Button, J. & Li, L. Dynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells. J. Biol. Chem. 289, 21584\u201321590 (2014).","journal-title":"J. Biol. Chem."},{"key":"220_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-014-0028-1","volume":"11","author":"MR Dillingh","year":"2014","unstructured":"Dillingh, M. R. et al. Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers. J. Inflamm. 11, 1\u20139 (2014).","journal-title":"J. Inflamm."},{"key":"220_CR28","doi-asserted-by":"publisher","first-page":"16185","DOI":"10.3390\/ijms242216185","volume":"24","author":"DM Foster","year":"2023","unstructured":"Foster, D. M. & Kellum, J. A. Endotoxic septic shock: diagnosis and treatment. Int. J. Mol. Sci. 24, 16185 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"220_CR29","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.febslet.2015.06.045","volume":"589","author":"M Ali","year":"2015","unstructured":"Ali, M., Saroha, A., Pewzner-Jung, Y. & Futerman, A. H. LPS-mediated septic shock is augmented in ceramide synthase 2 null mice due to elevated activity of TNF\u03b1-converting enzyme. FEBS Lett. 589, 2213\u20132217 (2015).","journal-title":"FEBS Lett."},{"key":"220_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/978-3-319-41986-2_25","volume":"2","author":"K Regulski","year":"2021","unstructured":"Regulski, K., Champion-Arnaud, P. & Gabard, J. Bacteriophage manufacturing: from early twentieth-century processes to current GMP. Bacteriophages Biol. Technol. Ther. 2, 699\u2013729 (2021).","journal-title":"Bacteriophages Biol. Technol. Ther."},{"key":"220_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.biotechadv.2018.03.021","volume":"36","author":"CH Goey","year":"2018","unstructured":"Goey, C. H., Alhuthali, S. & Kontoravdi, C. Host cell protein removal from biopharmaceutical preparations: Towards the implementation of quality by design. Biotechnol. Adv. 36, 1223\u20131237 (2018).","journal-title":"Biotechnol. Adv."},{"key":"220_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00216-021-03648-2","volume":"414","author":"K Pilely","year":"2022","unstructured":"Pilely, K. et al. Monitoring process-related impurities in biologics\u2013host cell protein analysis. Anal. Bioanal. Chem. 414, 747\u2013758 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"220_CR33","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1002\/bit.25647","volume":"112","author":"CLZ de Zafra","year":"2015","unstructured":"de Zafra, C. L. Z., Quarmby, V., Francissen, K., Vanderlaan, M. & Zhu-Shimoni, J. Host cell proteins in biotechnology-derived products: a risk assessment framework. Biotechnol. Bioeng. 112, 2284\u20132291 (2015).","journal-title":"Biotechnol. Bioeng."},{"key":"220_CR34","doi-asserted-by":"publisher","first-page":"465890","DOI":"10.1016\/j.chroma.2025.465890","volume":"1749","author":"JPP Saavedra","year":"2025","unstructured":"Saavedra, J. P. P., Silva-Santos, A. R., Duarte, S. O. D. & Azevedo, A. M. Scalable purification of bacteriophages preparations. J. Chromatogr. A 1749, 465890 (2025).","journal-title":"J. Chromatogr. A"},{"key":"220_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jchromb.2013.02.004","volume":"927","author":"A\u0160 Podgornik","year":"2013","unstructured":"Podgornik, A. \u0160, Yamamoto, S., Peterka, M. \u017d & Krajnc, N. L. Fast separation of large biomolecules using short monolithic columns. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 927, 80\u201389 (2013).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"220_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/elps.202200270","volume":"44","author":"T Rogerson","year":"2023","unstructured":"Rogerson, T. et al. Purification of a recombinant oncolytic virus from clarified cell culture media by anion exchange monolith chromatography. Electrophoresis 44, 1923\u20131933 (2023).","journal-title":"Electrophoresis"},{"key":"220_CR37","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/jssc.200500246","volume":"28","author":"M Barut","year":"2005","unstructured":"Barut, M., Podgornik, A., Brne, P. & \u0160trancar, A. Convective interaction media short monolithic columns: enabling chromatographic supports for the separation and purification of large biomolecules. J. Sep. Sci. 28, 1876\u20131892 (2005).","journal-title":"J. Sep. Sci."},{"key":"220_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.chroma.2012.10.062","volume":"1270","author":"J Lee","year":"2012","unstructured":"Lee, J. et al. Principles and applications of steric exclusion chromatography. J. Chromatogr. A 1270, 162\u2013170 (2012).","journal-title":"J. Chromatogr. A"},{"key":"220_CR39","doi-asserted-by":"crossref","unstructured":"Rebula, L., Raspor, A., Bav\u010dar, M., \u0160trancar, A. & Leskovec, M. CIM monolithic chromatography as a useful tool for endotoxin reduction and purification of bacteriophage particles supported with PAT analytics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1217, 123606 (2023).","DOI":"10.1016\/j.jchromb.2023.123606"},{"key":"220_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bpc.2004.06.012","volume":"112","author":"S Moelbert","year":"2004","unstructured":"Moelbert, S., Normand, B. & De Los Rios, P. Kosmotropes and chaotropes: modelling preferential exclusion, binding and aggregate stability. Biophys. Chem. 112, 45\u201357 (2004).","journal-title":"Biophys. Chem."},{"key":"220_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-0248(88)90296-5","volume":"90","author":"SN Timasheff","year":"1988","unstructured":"Timasheff, S. N. & Arakawa, T. Mechanism of protein precipitation and stabilization by co-solvents. J. Cryst. Growth 90, 39\u201346 (1988).","journal-title":"J. Cryst. Growth"},{"key":"220_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jchromb.2007.05.048","volume":"861","author":"F Smrekar","year":"2008","unstructured":"Smrekar, F., Ciringer, M., Peterka, M., Podgornik, A. & \u0160trancar, A. Purification and concentration of bacteriophage T4 using monolithic chromatographic supports. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 861, 177\u2013180 (2008).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"220_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.virol.2012.09.018","volume":"434","author":"EM Adriaenssens","year":"2012","unstructured":"Adriaenssens, E. M. et al. CIM(\u00ae) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology 434, 265\u2013270 (2012).","journal-title":"Virology"},{"key":"220_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.mimet.2016.11.020","volume":"132","author":"JD Van Belleghem","year":"2017","unstructured":"Van Belleghem, J. D., Merabishvili, M., Vergauwen, B., Lavigne, R. & Vaneechoutte, M. A comparative study of different strategies for removal of endotoxins from bacteriophage preparations. J. Microbiol. Methods 132, 153\u2013159 (2017).","journal-title":"J. Microbiol. Methods"},{"key":"220_CR45","doi-asserted-by":"crossref","unstructured":"Guan, J. & Bondy-Denomy, J. Intracellular Organization by Jumbo Bacteriophages. J. Bacteriol. 203, e00362-20 (2020).","DOI":"10.1128\/JB.00362-20"},{"key":"220_CR46","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/s41564-022-01243-4","volume":"7","author":"J Guan","year":"2022","unstructured":"Guan, J. et al. Bacteriophage genome engineering with CRISPR\u2013Cas13a. Nat. Microbiol. 7, 1956\u20131966 (2022).","journal-title":"Nat. Microbiol."},{"key":"220_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld, J., McKenna, S. A. & Patel, T. R. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys. Rev. 8, 409\u2013427 (2016).","journal-title":"Biophys. Rev."},{"key":"220_CR48","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.5jyl8xn69v2w\/v1","author":"A Echterhof","year":"2026","unstructured":"Echterhof, A. et al. Single-step monolithic chromatography for Pseudomonas aeruginosa phages purification. Protoc. io https:\/\/doi.org\/10.17504\/protocols.io.5jyl8xn69v2w\/v1 (2026).","journal-title":"Protoc. io"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00220-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00220-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:09:34Z","timestamp":1790672974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00220-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00220-6","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"46"}}